Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Mesoblast (MESO) Drug Pipeline

Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
Saline, Rexlemestrocel-L + Ha MixtureDegenerative Disc DiseasePhase IIIRecruitingEfficacy and Safety of Rexlemestrocel-L Combined With HA* in Participants With Moderate to Severe Chronic Low Back PainMar 15, 2024
ProchymalCrohn's DiseasePhase IIICompletedEvaluation of PROCHYMAL® for Treatment-refractory Moderate-to-severe Crohn's DiseaseNov 02, 2010―
ProchymalMyocardial InfarctionPhase IICompletedProchymal® (Human Adult Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction (AMI)Apr 07, 2009―
ProchymalDiabetes Mellitus, Insulin-Dependent, Type 1 Diabetes Mellitus, Type 1 Diabetes, Juvenile DiabetesPhase IICompletedPROCHYMAL® (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)Jun 02, 2008―
ProchymalPulmonary Disease, Chronic Obstructive, Chronic Bronchitis, Pulmonary EmphysemaPhase IICompletedPROCHYMAL™ (Human Adult Stem Cells) for the Treatment of Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)May 21, 2008―
Prochymal Adult Human Mesenchymal Stem CellsCrohn's DiseasePhase IIICompletedExtended Evaluation of PROCHYMAL® Adult Human Stem Cells for Treatment-Resistant Moderate-to-Severe Crohn's DiseaseOct 11, 2007―
ProchymalCrohn's DiseasePhase IIICompletedEvaluation of PROCHYMAL® Adult Human Stem Cells for Treatment-resistant Moderate-to-severe Crohn's DiseaseMay 30, 2007―

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Mesoblast (MESO) have in its pipeline
Mesoblast MESO is currently developing the following drugs: Saline, Rexlemestrocel-L + Ha Mixture, Prochymal, Prochymal Adult Human Mesenchymal Stem Cells. These drug candidates are in various stages of clinical development as the company works toward FDA approval.